Dergiler / Turkish journal of nephrology (Online) / 2022 / Cilt: 31 - Sayı: 3

Inflammation and Oxidative Stress Markers and Their Relationship in Kidney Transplant Recipients

Sayfa
250–256
Yayın Tarihi
2022-11-03
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These processes initiated by the body in order to defend itself may damage the tissues after a certain stage, so further studies investigating treatment strategies for reducing inflammation and oxidative stress load and their effects on the prognosis of kidney transplant recipients are needed.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Inflammation and oxidative stress are the 2 well-known physiopathological processes involved in the onset and progression of atherosclerosis and can play role in the poor prognosis of kidney transplantation.
📊
Temel Bulgular & Veri:Methods: This study was carried out with 62 kidney transplant recipients (34 females and 28 males) who had received a successful transplant at least before 6 months.
💡
Sonuç & Katkı:These processes initiated by the body in order to defend itself may damage the tissues after a certain stage, so further studies investigating treatment strategies for reducing inflammation and oxidative stress load and their effects on the prognosis of kidney transplant recipients are needed.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Inflammation and oxidative stress are the 2 well-known physiopathological processes involved in the onset and progression of atherosclerosis and can play role in the poor prognosis of kidney transplantation. However, there is no satisfactory evidence for their markers to be used for the diagnosis and/or follow-up of cardiovascular disease in daily practice. We aimed to investigate inflammation and oxidative stress markers in kidney transplant recipients long after transplantation. Methods: This study was carried out with 62 kidney transplant recipients (34 females and 28 males) who had received a successful transplant at least before 6 months. A group of 50 healthy individuals (28 females and 22 males) were selected as controls. Results: Homocysteine, advanced glycation end products, high sensitivity C-reactive protein, insulin-like growth factor-1, protein S-100B, and vitamin A levels were higher; vitamin E levels and paraoxonase and arylesterase activities were significantly lower in kidney transplant recipients. Conclusion: Kidney transplant recipients are exposed to inflammation and oxidative stress a long time after kidney transplantation. These processes initiated by the body in order to defend itself may damage the tissues after a certain stage, so further studies investigating treatment strategies for reducing inflammation and oxidative stress load and their effects on the prognosis of kidney transplant recipients are needed.

🔖

Bu Makaleye Atıf Yap

KOCA, N., KAÇAN, S. B., KIRHAN, E., DİRİCAN, M., SARANDOL, E., ERSOY, A. (2022). Inflammation and Oxidative Stress Markers and Their Relationship in Kidney Transplant Recipients. Turkish journal of nephrology (Online), Cilt: 31 - Sayı: 3, 250–256. https://ajindex.com/articles/612826

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Recio-Mayoral A, Banerjee D, Streather C, Kaski JC. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease – a cross-sectional study of predialysis, dialysis and kidne y-transplantation patients. Atherosclerosis. 2011
  2. 216(2):446-451. [CrossRef] 2. Cozlea DL, Farcas DM, Nagy A, et al. The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease. Curr Health Sci J. 2013
  3. 39(4):225-231. 3. Liu X, Liu K, Wang Z, et al. Advanced glycation end products accelerate arteriosclerosis after renal transplantation through the AGE/RAGE/ILK pathway. Exp Mol Pathol. 2015
  4. 99(2):312-319. [CrossRef] 4. DaffuG, del PozoCH, O'SheaKM, AnanthakrishnanR, RamasamyR, Schmidt AM. Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. Int J Mol Sci. 2013
  5. 14(10):19891-19910. [CrossRef] 5. Lioudaki S, Verikokos C, Kouraklis G, et al. Paraoxonase-1: characteristics and role in atherosclerosis and carotid artery disease. Curr Vasc Pharmacol. 2019
  6. 17(2):141-146. [CrossRef] 6. Wallert M, Schmölz L, Galli F, Birringer M, Lorkowski S. Regulatory metabolites of vitamin E and their putative relevance for atherogenesis. Redox Biol. 2014
  7. 2(2):495-503. [CrossRef] 7. Sztanek F, Seres I, Harangi M, et al. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease. Nephrol Dial Transplant. 2012
  8. 27(7):2866-2872. [CrossRef] 8. Janda K, Aksamit D, Drozdz M, et al. Influence of elevated homocystein level and selected lipid parameters in kidney transplant patients on the progression of atherosclerotic changes assessed by intima-media thickness index (CCA-IMT). Przegl Lek. 2012
  9. 69(9):670-674. 9. Conti E, Carrozza C, Capoluongo E, et al. Insulin-like growth factor-1 as a vascular protective factor. Circulation. 2004
  10. 110(15):2260- 2265. [CrossRef] 10. Kawachi S, TakedaN, Sasaki A, et al. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2005
  11. 25(3):617-621. [CrossRef] 11. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonas e/arylesterase polymorphism. Am J Hum Genet. 1983
  12. 35(6): 1126-1138. 12. Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate